During the past decade, UCLA CTRC Outpatient Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UCLA CTRC Outpatient Unit" are "Clostridium Difficile Infection" (1 trials) and "Staphylococcal Vaccine" (1 trials). Many other conditions were trialed in "UCLA CTRC Outpatient Unit" in a lesser frequency.

Most popular intervention types in "UCLA CTRC Outpatient Unit" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Clostridium difficile vaccine" (1 trials) and "Staphylococcus aureus 4-Antigen (SA4Ag) Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCLA CTRC Outpatient Unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "UCLA CTRC Outpatient Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UCLA CTRC Outpatient Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UCLA CTRC Outpatient Unit, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".